PUBLIC COMPANY BRIEF
Endpoint Health
Precision-first therapies
- YC batch
- Winter 2019
- Reported status
- inactive
- Reported location
- San Francisco, CA, USA; Palo Alto, CA, USA; Remote
Read the public briefing for free. The thesis, evidence, validation playbook, and MVP prompt require authorized access.